Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 51
Filter
Add more filters










Publication year range
1.
Vestn Oftalmol ; 138(1): 52-56, 2022.
Article in Russian | MEDLINE | ID: mdl-35234421

ABSTRACT

The article presents a case of complicated viral conjunctivitis. Conjunctivitis was the initial sign of the new coronavirus infection (COVID-19) in the patient. The disease had a fairly long course and led to symmetrical scarring in the form of partial external symblepharon and dry eye syndrome. Ophthalmologists should be aware about this disease and its complications. Early treatment with corticosteroids in combination with symptomatic therapy can contribute to prevention of the development of conjunctival scarring. In addition to conjunctival scarring, this disease can possibly potentiate the development of keratitis, optic neuritis, and uveitis.


Subject(s)
COVID-19 , Conjunctivitis, Viral , Conjunctivitis , Ophthalmologists , COVID-19/diagnosis , Conjunctivitis/diagnosis , Conjunctivitis/etiology , Conjunctivitis, Viral/complications , Conjunctivitis, Viral/etiology , Humans , SARS-CoV-2
2.
Vestn Oftalmol ; 136(3): 87-92, 2020.
Article in Russian | MEDLINE | ID: mdl-32504482

ABSTRACT

The review presents the characteristics and results of clinical studies on implantation of different types of macular lenses (IOL-VIP system, Lipschitz Macular Implant (LMI), Fresnel Prism Intraocular, IOL AMD) installed in the capsular bag after phacoemulsification in patients with age-related macular degeneration (AMD). The literature review shows that up to now, the data on implantation of these lenses was contradictory and generally based only on short-term results. There are quite strict criteria for the selection of patients to evaluate the maximum possible postoperative visual rehabilitation of patients using special programs, the effectiveness of which largely depends on their commitment to postoperative, sometimes long-term treatment. Additional independent clinical studies with longer follow-up periods for patients with AMD are required to determine the efficacy and safety of macular lenses in order to recommend their use in wide clinical practice.


Subject(s)
Lenses, Intraocular , Macular Degeneration , Phacoemulsification , Humans , Lens Implantation, Intraocular , Postoperative Complications , Visual Acuity
3.
Vestn Oftalmol ; 130(2): 8-11, 2014.
Article in Russian | MEDLINE | ID: mdl-24864493

ABSTRACT

Surgical results of 76 patients (76 eyes) aged 25-79 years with secondary refractory glaucoma were analyzed. The best hypotensive effect and visual functions integrity were achieved with Ahmed valve implantation (86.7% and 83.3% of cases respectively); after conventional fistulizing surgery the hypotensive effect was observed in 45.5%, noncompromised vision--in 54.5% of cases. Tunnel trabeculectomy with iridocycloretraction led to normalization of intraocular pressure and stabilization of visual functions in 81.3% and 68.8% of cases respectively and thus can be considered as an alternative to fistulizing surgery in patients with secondary refractory glaucoma. Uveal glaucoma is a relative contraindication to Ahmed valve implantation, while neovascular glaucoma is that to tunnel trabeculectomy with iridocycloretraction.


Subject(s)
Glaucoma Drainage Implants , Glaucoma/etiology , Glaucoma/surgery , Adult , Aged , Female , Glaucoma/physiopathology , Humans , Intraocular Pressure , Male , Middle Aged , Tonometry, Ocular , Trabeculectomy , Treatment Outcome , Visual Acuity
4.
Vestn Oftalmol ; 128(5): 50-3, 2012.
Article in Russian | MEDLINE | ID: mdl-23210350

ABSTRACT

Neovascular glaucoma (NVG) is one of the most severe form of refractory glaucoma. Vascular endothelial growth factor (VEGF) is one of the strongest promoters of angiogenesis and was found to be the main neovascularization regulator. The use of anti-VEGF-agents is a rational option because in the majority of cases it allows to reach disappearance or reduction of neovascularization, that significantly reduces the risk of complications in following surgery or laser treatment of NVG.


Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Filtering Surgery/methods , Glaucoma, Neovascular , Neovascularization, Pathologic , Preoperative Care/methods , Vascular Endothelial Growth Factor A/metabolism , Angiogenesis Inhibitors/therapeutic use , Bevacizumab , Glaucoma, Neovascular/etiology , Glaucoma, Neovascular/metabolism , Glaucoma, Neovascular/physiopathology , Glaucoma, Neovascular/surgery , Humans , Injections, Intraocular , Neovascularization, Pathologic/complications , Neovascularization, Pathologic/metabolism , Neovascularization, Pathologic/physiopathology , Treatment Outcome
17.
Vestn Oftalmol ; 118(4): 34-6, 2002.
Article in Russian | MEDLINE | ID: mdl-12371321

ABSTRACT

Sixty-five patients (65 eyes) with traumatic uveitis were treated. Ultraviolet irradiation of autoblood was included in therapeutic complexes of 28 patients. 37 patients received traditional therapy (corticosteroids, nonsteroid inflammatory agents, etc.). Addition of UV exposure of autoblood to combined therapy for traumatic uveitis more effectively (92.9 vs. 75.7%) and sooner liquidated posttraumatic inflammatory reaction (8.10 +/- 1.5 vs. 12.7 +/- 1.7 days), decreased the hospital stay (11.0 +/- 2.0 vs. 15.8 +/- 1.3 days), and eventually more often improved the visual acuity (in 42.9 vs. 24.3% patients). Hence, UV exposure of autoblood is an effective, safe, and virtually atraumatic method of treatment.


Subject(s)
Blood/radiation effects , Eye Injuries/therapy , Ultraviolet Rays , Uveitis/therapy , Adolescent , Adult , Aged , Eye Injuries/blood , Female , Follow-Up Studies , Humans , Male , Middle Aged , Time Factors , Uveitis/blood , Visual Acuity
SELECTION OF CITATIONS
SEARCH DETAIL
...